Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 09/30 10:01:34 pm
7.69 USD   +1.59%
09/29 RITE AID : DreamShip Hot Air Balloon, Designed by Children of Americ..
09/29 RITE AID : to honor local scholarship recipients on Friday
09/28 RITE AID : How a pharmacy helped sons of late Air Force captain
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
09/29 Deductibles For Employer Healthcare Plans Soar, Kaiser Family Foundation Repo..
09/29 RITE AID : DreamShip Hot Air Balloon, Designed by Children of America’s Mi..
09/29 RITE AID : to honor local scholarship recipients on Friday
09/28 RITE AID : How a pharmacy helped sons of late Air Force captain
09/27 RITE AID : Expands Naloxone Dispensing Program in Four Additional States
09/27 RITE AID : Flu shot clinic in North Tonawanda
09/26 RITE AID CORPORATION : Post Earnings Coverage as Rite Aid Q2 Topline Registers G..
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/22 RITE AID CORP : Results of Operations and Financial Condition, Financial Stateme..
More news
Sector news : Retail - Drugs without Grocery
09/30DJJ SAINSBURY : Sainsbury Appoints Walgreens Boots' Simon Roberts As Retail Direct..
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/14DJGoogle Acquisition Apigee's Revenue Climbs
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
09/30 RITE AID/WALGREENS BOOTS ALLIANCE DE : Potential Gains Gone Up, Risk Not Much
09/28 Walmart's Next Move Against Amazon
09/28 PE firms snooze on 650-unit Walgreens sale
09/25 Insights From Rite Aid's 2nd Quarter
09/23 RITE-AID : We Just Don't Know
Advertisement
Financials ($)
Sales 2017 32 856 M
EBIT 2017 680 M
Net income 2017 147 M
Debt 2017 6 848 M
Yield 2017 -
P/E ratio 2017 52,72
P/E ratio 2018 33,72
EV / Sales 2017 0,45x
EV / Sales 2018 0,43x
Capitalization 7 941 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 8,83 $
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-3.44%7 941
RAIA DROGASIL SA89.12%6 725
AIN HOLDINGS INC19.51%2 192
ORIOLA KD OYJ-5.32%832
AUSTRALIAN PHARMACEUTI..-1.30%726
ADCOCK INGRAM HOLDINGS..-6.14%584
More Results